ATN-103

DRUG3 trials

Sponsors

Ablynx, a Sanofi company

Conditions

Active Rheumatoid ArthritisHealthyRheumatoid Arthritis

Phase 1

Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects

CompletedNCT00916110

Ablynx, a Sanofi companyHealthy

Start: 2008-11-30End: 2009-11-30Updated: 2013-01-16

Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis

CompletedNCT00959036

Ablynx, a Sanofi companyActive Rheumatoid Arthritis

Start: 2009-09-30End: 2011-01-31Updated: 2013-01-30

Phase 2

Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis

CompletedNCT01063803

Ablynx, a Sanofi companyRheumatoid Arthritis

Start: 2010-02-28End: 2012-02-29Updated: 2016-04-11